Dr. Donald R. Royall Jr., MD

Dr. Royall practices at UT Health San Antonio in San Antonio, Texas.

Dr. Royall's NPI, 1689683021, was assigned on August 5, 2006. Dr. Royall graduated from McGovern Medical School in 1984. Dr. Royall's Texas license number on file is G9385.

Dr. Royall's primary practice is UT Health San Antonio, at 8431 Fredericksburg Rd, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 450-9000.

Dr. Royall's primary practice is UT Health San Antonio in San Antonio, Texas. Dr. Royall is also affiliated with UT Health San Antonio Multispecialty and Research Hospital. The medical group on file is UT Health Physicians. Dmand AI also links Dr. Royall to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Royall practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Royall's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Royall is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Royall's licenses on file in 2 states: Texas and Maryland.

Dmand AI lists adjustment disease, anxiety, bipolar disorder, depression, insomnia, non-alzheimer's dementia (chronic) and schizophrenia among the conditions Dr. Royall treats.

CMS data shows 328 Medicare services from Dr. Royall across 3 procedure codes in 2024, all of them office visits, for 164 Medicare patients. Medicare paid $31,037 for them. Every service was in an office.

CMS counts 164 Medicare patients who saw Dr. Royall in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have depression, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Royall's median patient age at 74, with 64% women.

In 2024, Dr. Royall wrote 4,004 Medicare Part D claims for 350 patients. 98% of them were for generic drugs. CMS names the drug for 3,862 of them, across 38 drugs with 11 or more claims each, at $90,427 in total drug cost. In 2023, CMS named 3,500 claims across 36 drugs.

Dr. Royall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Royall as offering telehealth.

Dmand AI links 134 papers to Dr. Royall, published from 2006 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Neuropsychological Tests, Alzheimer Disease and Dementia. Dr. Royall has published most often in J Neuropsychiatry Clin Neurosci. Dr. Royall's most frequent co-authors are Jason E. Schillerstrom, MD, Laura K. Chiodo, MD and Peter T. Fox, MD.

CMS Open Payments shows 23 general payments to Dr. Royall from 4 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 53% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,341.

Dr. Royall graduated from McGovern Medical School in 1984.

Dr. Royall is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.